Parkinson’s disease market

View All

emerging-therapies-for-pd-lid-treatment
Need of the Hour: Enhanced Strategies for PD-LID Treatment and Management

Parkinson’s disease (PD) is a degenerative neurological condition primarily affecting middle-aged and older adults and is characterized by tremors, muscular rigidity, and slow, clumsy movement. It is connected to the brain’s basal ganglia atrophy and a lack of the neurotransmitter dopamine. Levodopa is considered a...

Find More

parkinsons-disease-treatment-market
Most Promising Therapies in the Parkinson’s Disease Treatment Market

Parkinson's disease (PD) is the second most prevalent neurogenerative disorder, with a growing global prevalence due to population aging. Despite increased awareness and significant research advancement, Parkinson’s disease treatment options include dopamine replacement therapy, symptomatic therapies that have sign...

Find More

progressive-parkinsons-disease-market
Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market

Parkinson's disease is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Parkinson's disease has four main symptoms such as tremor (trembling) in hands, arms, legs, jaw, or head, stiffness of the limbs and tru...

Find More

Parkinson's disease Therapy Market
Parkinson’s Disease Market: Impact of Emerging therapies on Parkinson’s therapeutics market

Parkinson's disease prevalence is rising. According to a survey conducted by Parkinson.org, around one million people in the US will be living with Parkinson’s disease by the end of 2020. The number is shockingly high as the prevalence of multiple sclerosis combined with muscular dystrophy and Lou Gehrig’s dise...

Find More